ロード中...
miR-509 suppresses brain metastasis of breast cancer cells by modulating RhoC and TNF α
The median survival time of breast cancer patients with brain metastasis is less than 6 months, and even a small metastatic lesion often causes severe neurological disabilities. Because of the location of metastatic lesions, a surgical approach is limited and most chemotherapeutic drugs are ineffect...
保存先:
| 出版年: | Oncogene |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4530094/ https://ncbi.nlm.nih.gov/pubmed/25659578 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2014.412 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|